Clover Health Investments, CORP /DE Form 4 insider transactions

NASDAQ
Clover Health's Chief Technology Officer, Conrad Wai, disposed of shares to cover tax obligations arising from the vesting of restricted stock units.
NASDAQ
Jamie Reynoso, CEO of Medicare Advantage at Clover Health, disposed of 7,777 shares of Class A Common Stock to cover tax obligations upon the vesting of restricted stock units (RSUs).
NASDAQ
Director Anna U. Loengard reports purchasing 137,000 shares of Clover Health Investments, Corp. at an average price of $0.73 per share.